{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:50:08Z","timestamp":1777323008006,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001105"],"award-info":[{"award-number":["UL1TR001105"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1245\/s10434-018-6388-7","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T13:23:15Z","timestamp":1519737795000},"page":"1193-1201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study"],"prefix":"10.1245","volume":"25","author":[{"given":"Ibrahim","family":"Nassour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A.","family":"Mokdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Porembka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Choti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricio M.","family":"Polanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca M.","family":"Minter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam C.","family":"Yopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"6388_CR1","doi-asserted-by":"publisher","unstructured":"Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463\u201373 discussion 473\u20135. https:\/\/doi.org\/10.1097\/00000658-199610000-00005 .","DOI":"10.1097\/00000658-199610000-00005"},{"issue":"2","key":"6388_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0002-9343(65)90178-6","volume":"38","author":"G Klatskin","year":"1965","unstructured":"Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med. 1965;38(2):241\u201356.","journal-title":"Am J Med."},{"issue":"14","key":"6388_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381. https:\/\/doi.org\/10.1056\/nejmoa0908721 .","journal-title":"N Engl J Med."},{"issue":"1","key":"6388_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1634\/theoncologist.9-1-43","volume":"9","author":"CD Anderson","year":"2004","unstructured":"Anderson CD, Pinson CW, Berlin J, Chari RS. Diagnosis and treatment of cholangiocarcinoma. Oncologist. 2004;9(1):43\u201357. https:\/\/doi.org\/10.1634\/theoncologist.9-1-43 .","journal-title":"Oncologist."},{"issue":"4","key":"6388_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1067\/msy.2002.127555","volume":"132","author":"A Nakeeb","year":"2002","unstructured":"Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery. 2002;132(4):555\u201364. https:\/\/doi.org\/10.1067\/msy.2002.127555 .","journal-title":"Surgery."},{"issue":"5","key":"6388_CR6","first-page":"628","volume":"224","author":"R Pichlmayr","year":"1996","unstructured":"Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg. 1996;224(5):628\u201338.","journal-title":"A single-center experience. Ann Surg."},{"issue":"8","key":"6388_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/hpb.12450","volume":"17","author":"JC Mansour","year":"2015","unstructured":"Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey J-N. Hilar Cholangiocarcinoma: expert consensus statement. HPB. 2015;17(8):691\u20139. https:\/\/doi.org\/10.1111\/hpb.12450 .","journal-title":"HPB."},{"issue":"4","key":"6388_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507.","journal-title":"Ann Surg."},{"issue":"6","key":"6388_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00268-007-9001-y","volume":"31","author":"S Hasegawa","year":"2007","unstructured":"Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007;31(6):1258\u201365. https:\/\/doi.org\/10.1007\/s00268-007-9001-y .","journal-title":"World J Surg."},{"issue":"5","key":"6388_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.sla.0000160701.38945.82","volume":"241","author":"AW Hemming","year":"2005","unstructured":"Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241(5):693.","journal-title":"Ann Surg."},{"issue":"4","key":"6388_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/13651820500373010","volume":"7","author":"H Nishio","year":"2005","unstructured":"Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford). 2005;7(4):259\u201362. https:\/\/doi.org\/10.1080\/13651820500373010 .","journal-title":"HPB (Oxford)."},{"issue":"8","key":"6388_CR12","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/cncr.11699","volume":"98","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma. Cancer. 2003;98(8):1689\u2013700. https:\/\/doi.org\/10.1002\/cncr.11699 .","journal-title":"Cancer."},{"issue":"1","key":"6388_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijrobp.2010.05.001","volume":"81","author":"TZ Vern-Gross","year":"2011","unstructured":"Vern-Gross TZ, Shivnani AT, Chen K, et al. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results Analysis. Int J Radiat Oncol Biol Phys. 2011;81(1):189\u201398.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"6388_CR14","doi-asserted-by":"crossref","unstructured":"Pitt HA, Nakeeb A, Abrams RA, et al. Perihilar cholangiocarcinoma. postoperative radiotherapy does not improve survival. Ann Surg. 1995;221(6):788\u201397; discussion 797\u20138.","DOI":"10.1097\/00000658-199506000-00017"},{"issue":"1","key":"6388_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0002-9610(05)80612-9","volume":"159","author":"JL Cameron","year":"1990","unstructured":"Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg. 1990;159(1):91\u20138.","journal-title":"Am J Surg."},{"issue":"16","key":"6388_CR16","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","volume":"30","author":"AM Horgan","year":"2012","unstructured":"Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30(16):1934\u201340. https:\/\/doi.org\/10.1200\/jco.2011.40.5381 .","journal-title":"J Clin Oncol."},{"issue":"7","key":"6388_CR17","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s00595-005-2989-4","volume":"35","author":"N Sagawa","year":"2005","unstructured":"Sagawa N, Kondo S, Morikawa T, Okushiba S, Katoh H. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg Today. 2005;35(7):548\u201352. https:\/\/doi.org\/10.1007\/s00595-005-2989-4 .","journal-title":"Surg Today."},{"issue":"2","key":"6388_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejso.2006.09.033","volume":"33","author":"Q Cheng","year":"2007","unstructured":"Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M. Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival. Eur J Surg Oncol (EJSO). 2007;33(2):202\u20137.","journal-title":"Eur J Surg Oncol (EJSO)."},{"issue":"5","key":"6388_CR19","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1016\/j.ijrobp.2010.12.019","volume":"81","author":"TH Kim","year":"2011","unstructured":"Kim TH, Han S-S, Park S-J, et al. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer. Int J Radiat Oncol Biol Phys. 2011;81(5):e853\u20139.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"24","key":"6388_CR20","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","volume":"33","author":"E Ben-Josef","year":"2015","unstructured":"Ben-Josef E, Guthrie KA, El-Khoueiry AB, et al. SWOG S0809: A Phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33(24):2617\u201322. https:\/\/doi.org\/10.1200\/jco.2014.60.2219 .","journal-title":"J Clin Oncol."},{"issue":"10","key":"6388_CR21","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s00268-016-3551-9","volume":"40","author":"MJ Kang","year":"2016","unstructured":"Kang MJ, Jang J-Y, Chang J, et al. Actual long-term survival outcome of 403 consecutive patients with hilar cholangiocarcinoma. World J Surg. 2016;40(10):2451\u20139. https:\/\/doi.org\/10.1007\/s00268-016-3551-9 .","journal-title":"World J Surg."},{"key":"6388_CR22","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.2147\/OTT.S131873","volume":"10","author":"KM Leng","year":"2017","unstructured":"Leng KM, Liu YP, Wang ZD, et al. Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection. Onco Targets Ther. 2017;10:2257\u201366. https:\/\/doi.org\/10.2147\/ott.s131873 .","journal-title":"Onco Targets Ther."},{"issue":"2","key":"6388_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00595-016-1354-0","volume":"47","author":"T Mizuno","year":"2017","unstructured":"Mizuno T, Ebata T, Yokoyama Y, et al. Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis. Surg Today. 2017;47(2):182\u201392. https:\/\/doi.org\/10.1007\/s00595-016-1354-0 .","journal-title":"Surg Today."},{"issue":"6","key":"6388_CR24","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00280-017-3312-y","volume":"79","author":"S-W Kim","year":"2017","unstructured":"Kim S-W, Noh OK, Kim JH, et al. Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer. Cancer Chemother Pharmacol. 2017;79(6):1161\u20137. https:\/\/doi.org\/10.1007\/s00280-017-3312-y .","journal-title":"Cancer Chemother Pharmacol."},{"key":"6388_CR25","unstructured":"NCCN Clinical Practice Guidlines in Oncology. Hepatobiliary cancers. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary_blocks.pdf . Accessed 6 Feb 2017."},{"key":"6388_CR26","unstructured":"National Cancer Data Base. https:\/\/www.facs.org\/quality%20programs\/cancer\/ncdb . Published July 4, 2016. Accessed 4 July 2016."},{"issue":"2","key":"6388_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10260-007-0086-0","volume":"18","author":"A Mattei","year":"2008","unstructured":"Mattei A. Estimating and using propensity score in presence of missing background data: an application to assess the impact of childbearing on wellbeing. Stat Methods Appl. 2008;18(2):257\u201373. https:\/\/doi.org\/10.1007\/s10260-007-0086-0 .","journal-title":"Stat Methods Appl."},{"issue":"7","key":"6388_CR28","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/sim.5984","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33(7):1242\u201358. https:\/\/doi.org\/10.1002\/sim.5984 .","journal-title":"Stat Med."},{"issue":"23","key":"6388_CR29","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","volume":"31","author":"A Giobbie-Hurder","year":"2013","unstructured":"Giobbie-Hurder A, Gelber RD, Regan MM. Challenges of guarantee-time bias. J Clin Oncol. 2013;31(23):2963\u20139. https:\/\/doi.org\/10.1200\/jco.2013.49.5283 .","journal-title":"J Clin Oncol."},{"issue":"8","key":"6388_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/bjs.8813","volume":"99","author":"RAM Damhuis","year":"2012","unstructured":"Damhuis RAM, Wijnhoven BPL, Plaisier PW, Kirkels WJ, Kranse R, van Lanschot JJ. Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types. Br J Surg. 2012;99(8):1149\u201354. https:\/\/doi.org\/10.1002\/bjs.8813 .","journal-title":"Br J Surg."},{"issue":"2","key":"6388_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/SLA.0000000000000482","volume":"260","author":"AK Talsma","year":"2014","unstructured":"Talsma AK, Lingsma HF, Steyerberg EW, Wijnhoven BPL, Van Lanschot JJB. The 30-day versus in-hospital and 90-day mortality after esophagectomy as indicators for quality of care. Ann Surg. 2014;260(2):267\u201373. https:\/\/doi.org\/10.1097\/sla.0000000000000482 .","journal-title":"Ann Surg."},{"issue":"25","key":"6388_CR32","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107. https:\/\/doi.org\/10.1002\/sim.3697 .","journal-title":"Stat Med."},{"key":"#cr-split#-6388_CR33.1","unstructured":"R Core Team: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. [Internet], 2015. https:\/\/www.R-project.org\/;"},{"key":"#cr-split#-6388_CR33.2","doi-asserted-by":"crossref","unstructured":"Ref2 Sekhon J: Multivariate and Propensity Score Matching Software with Automated Balance Optimization: The Matching Package for R. J Stat Softw 42:1\u201352.","DOI":"10.18637\/jss.v042.i07"},{"issue":"21","key":"6388_CR34","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMsr077003","volume":"357","author":"R Wang","year":"2007","unstructured":"Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine\u2013reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189\u201394. https:\/\/doi.org\/10.1056\/nejmsr077003 .","journal-title":"N Engl J Med."},{"issue":"5","key":"6388_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","volume":"6","author":"MA Brookhart","year":"2013","unstructured":"Brookhart MA, Wyss R, Layton JB, St\u00fcrmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes. 2013;6(5):604\u201311. https:\/\/doi.org\/10.1161\/circoutcomes.113.000359 .","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"8","key":"6388_CR36","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"T Takada","year":"2002","unstructured":"Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? Cancer. 2002;95(8):1685\u201395. https:\/\/doi.org\/10.1002\/cncr.10831 .","journal-title":"Cancer."},{"key":"6388_CR37","unstructured":"Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.| 2017 Gastrointestinal Cancers Symposium Abstracts."},{"key":"6388_CR38","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.4006","author":"JN Primrose","year":"2017","unstructured":"Primrose JN, Fox R, Palmer DH, et al. Adjuvant capecitabine for biliary tract cancer: the BILCAP randomized study. J Clin Oncol. 2017. https:\/\/doi.org\/10.1200\/jco.2017.35.15_suppl.4006 .","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6388-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6388-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6388-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T19:53:10Z","timestamp":1570823590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6388-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["6388"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6388-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"29 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}